Why did Addus HomeCare (ADUS) stock move recently?

On 7/28/2026, Addus HomeCare moved +3.1% — No company-specific catalyst or filing was reported; ADUS rose with the broader market or healthcare sector. This is MarketChacha's decoded reason from filings and credible news; it is education, not buy/sell advice.

Is Addus HomeCare (ADUS) overvalued or fairly valued?

MarketChacha shows Addus HomeCare's valuation in context — a trailing P/E of about 22.6, a forward P/E of about 15.9, a price-to-book of about 1.9 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does Addus HomeCare's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (1.47×) from reported figures — education, not a rating.

What is Addus HomeCare's revenue?

Addus HomeCare reported revenue of $1.4B for FY2025, with net profit of $95.9M, per official filings.

What is the share price of Addus HomeCare (ADUS)?

Addus HomeCare last traded at $119.34 (-0.3% on the day), as of 8/10/2026 — a delayed quote shown for education, not investment advice.

Addus HomeCare

ADUS · NYSE · Healthcare · United States

Snapshot

TickerADUS

ExchangeNYSE

SectorHealthcare

IndustryMedical Care Facilities

CountryUnited States

Employees5,982

HeadquartersFrisco, United States

Websitewww.addus.com

Filings tracked14

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. Its Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company serves federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.

Who owns it

Insiders2.8%
Institutions97.2%
Public & other0.0%

421 institutional holders

Ownership breakdown from public market data.

Top holders

Blackrock Inc.18.34%
Capital Research Global Investors8.22%
Vanguard Capital Management LLC4.20%
State Street Corporation4.17%
Dimensional Fund Advisors LP3.98%
Silvercrest Asset Management Group, LLC3.90%
Wasatch Advisors LP3.65%
Geode Capital Management, LLC2.58%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Cash conversion1.47×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend5.9% → 6.7%

Margin has held broadly steady over the period — stable profitability.

Growth qualityrev 16% · PAT 24%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $394.1M · EPS 1.89

Est. earnings growth +6.9%

Next fiscal year

Rev $1.6B · EPS 7.52

Est. earnings growth +6.7%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$1.4B

Net margin

6.7%

ROE

8.8%

Revenue CAGR (2y)

+15.9%

Profit CAGR (2y)

+23.9%

EPS (FY2025)

5.22

Net profit (FY2025)

$95.9M

Ask MarketChacha about ADUS

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

Jul 28, 2026
No company-specific catalyst or filing was reported; ADUS rose with the broader market or healthcare sector.
· confidence: low
Jul 27, 2026
No clear company-specific catalyst found in filings or recent coverage; the stock rose alongside broader market or sector moves ahead of expected Q2 earnings.
· confidence: low

Daily moves with the verified reason behind them. Education only — not investment advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$1.4B	$95.9M	5.22	6.7%	8.8%
FY2024	$1.2B	$73.6M	4.23	6.4%	7.6%
FY2023	$1.1B	$62.5M	3.83	5.9%	8.8%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$377.4M	$27.6M	1.49	7.3%
2026Q1	$363.6M	$25.1M	1.36	6.9%
2025Q3	$362.3M	$22.8M	1.24	6.3%
2025Q2	$349.4M	$22.1M	1.20	6.3%
2025Q1	$337.7M	$21.2M	1.16	6.3%
2024Q3	$289.8M	$20.2M	1.10	7.0%
2024Q2	$286.9M	$18.1M	1.10	6.3%
2024Q1	$280.7M	$15.8M	0.97	5.6%
2023Q3	$270.7M	$15.4M	0.95	5.7%
2023Q2	$260.0M	$14.9M	0.91	5.7%
2023Q1	$251.6M	$12.7M	0.78	5.0%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

10-Q — FORM 10-Q
SEC8/4/2026
8-K — Results of operations, Reg FD disclosure, Exhibits
SEC8/3/2026material
8-K — Shareholder vote results
SEC6/10/2026material
10-Q — FORM 10-Q
SEC5/5/2026
8-K — Results of operations, Reg FD disclosure, Exhibits
SEC5/4/2026material
10-K/A — FORM 10-K/A
SEC3/12/2026
10-K — FORM 10-K
SEC2/24/2026
8-K — Results of operations, Reg FD disclosure, Exhibits
SEC2/23/2026material

2025

10-Q — FORM 10-Q
SEC11/4/2025
8-K — Results of operations, Reg FD disclosure, Exhibits
SEC11/3/2025material
8-K/A — Exhibits
SEC8/27/2025
8-K — Executive/director change, Reg FD disclosure, Exhibits
SEC8/7/2025material
10-Q — FORM 10-Q
SEC8/5/2025
8-K — Results of operations, Reg FD disclosure, Exhibits
SEC8/4/2025material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.